UCM710
UCM710 is an endocannabinoid (eCB) hydrolysis inhibitor that increases the levels of N-arachidonoyl ethanolamine and 2-arachidonoylglycerol in neurons. UCM710 inhibits fatty acid amide hydrolase and α/β-hydrolase domain 6, but not monoacylglycerol lipase[1].
Product Specifications
CAS Number
213738-77-3
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ucm710.html
Solubility
10 mM in DMSO
Smiles
CCCCCC/C=C\CCCCCCCC(OCC1OC1)=O
Molecular Formula
C19H34O3
Molecular Weight
310.47
References & Citations
[1]Marrs WR, et al. Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. J Biol Chem. 2011 Aug 19;286 (33) :28723-28728.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx013319-01 10 µg
Transforming Acidic Coiled-Coil Containing Protein 1 (TACC1) Antibody
Sign In for Pricing
View Details abx013319-02 100 µg
Transforming Acidic Coiled-Coil Containing Protein 1 (TACC1) Antibody
Sign In for Pricing
View Details abx013319-03 200 µg
Transforming Acidic Coiled-Coil Containing Protein 1 (TACC1) Antibody
Sign In for Pricing
View Details abx013319-04 300 µg
Transforming Acidic Coiled-Coil Containing Protein 1 (TACC1) Antibody
Sign In for Pricing
View Details abx013319-05 1 mg
Transforming Acidic Coiled-Coil Containing Protein 1 (TACC1) Antibody
Sign In for Pricing
View Details